NOVARTIS
Sustainability at Novartis The Novartis social impact and sustainability strategy defines how we aim to create value for patients and society, by focusing on maximizing the impact of our medicines to unlock better health for overlooked communities.
Supporting this are the fundamentals of how we aim to do business:
• Protecting the planet while advancing human health
• Advancing our people and culture to achieve shared success
• Embedding ethics across the business
“ It takes approximately 10 to 12 years for a new drug to go from labs to patients,” Korab explains.“ We want to anticipate barriers from the earliest stage, whether it’ s packaging, formulation or even temperature sensitivity so that our scientific breakthroughs have the opportunity to reach most patients.”
The company’ s work on global health is about addressing neglected tropical diseases and malaria in lowand middle-income countries. These conditions affect millions but attract little commercial research investment. Novartis aims to use its scientific engine for public good in these underserved areas.
24 January 2026